Commentary: Usage of intravitreal steroids in endophthalmitis: Horns of a dilemma
- PMID: 35918924
- PMCID: PMC9672774
- DOI: 10.4103/ijo.IJO_3161_21
Commentary: Usage of intravitreal steroids in endophthalmitis: Horns of a dilemma
Conflict of interest statement
None
Comment in
-
Commentary: Dexamethasone and dilemma.Indian J Ophthalmol. 2022 Aug;70(8):2842-2843. doi: 10.4103/ijo.IJO_3213_21. Indian J Ophthalmol. 2022. PMID: 35918925 Free PMC article. No abstract available.
Comment on
-
Visual outcomes of acute bacterial endophthalmitis treated with adjuvant intravitreal dexamethasone: A meta-analysis and systematic review.Indian J Ophthalmol. 2022 Aug;70(8):2835-2841. doi: 10.4103/ijo.IJO_955_21. Indian J Ophthalmol. 2022. PMID: 35918923 Free PMC article.
References
-
- Majji AB, Jalali S, Das T, Gopinathan U. Role of intravitreal dexamethasone in exogenous fungal endophthalmitis. Eye (Lond) 1999;13:660–5. - PubMed
-
- Sauer A, Candolfi E, Gaucher D, Creuzot-Garcher C, Bron A, Chiquet C, et al. Intraocular cytokine levels in post-cataract endophthalmitis and their association with visual outcome. Ocul Immunol Inflamm? 2018;26:964–70. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
